<DOC>
	<DOCNO>NCT00055250</DOCNO>
	<brief_summary>The purpose study determine effectiveness side effect LY293111 give combination gemcitabine patient pancreatic cancer .</brief_summary>
	<brief_title>A Study With LY293111 , Gemcitabine Placebo Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Adenocarcinoma pancreas locally advance metastatic amenable resection curative intent Tumor measure xray scan Adequate organ function Inability swallow capsule Documented brain metastasis Prior chemotherapy biological therapy disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>